Product Information

LORAZEPAM 0.5 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0364 per EA under NDC 00093342501. Its NADAC has been published 247 times since Feb 23, 2022.

FDA first approved this application on Oct 31, 1991. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LORAZEPAM 0.5 MG TABLET

Lorazepam
$0.0364per EA
DEA Schedule CIV

Strength

.5 mg/1

NDC

00093342501

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

LORAZEPAM

Approval Type

Generic (ANDA)

FDA Application

ANDA072926

FDA Approved

10/31/1991

TE Code

AB

On Market Since

10/11/2021

Pharmacological Classes

Benzodiazepine
Benzodiazepines

Price Statistics

The NADAC for LORAZEPAM 0.5 MG TABLET has been published 247 times since Feb 23, 2022, and over the history we have for it it has declined 9.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0364 per EA
All-time high$0.0464 (Mar 13, 2024)
All-time low$0.0315 (Nov 20, 2024)
52-week high$0.0430
52-week low$0.0328
Median price$0.0398
Average price$0.0395
Largest weekly change+28.1% (Aug 21, 2024)
Weeks tracked247
Tracking sinceFeb 23, 2022

Price History

1W

0.0%

1M

+5.6%

3M

+11.0%

6M

+8.5%

1Y

-15.2%

3Y

-9.5%

5Y

N/A

All

-9.0%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 44% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LORAZEPAM 0.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LORAZEPAM 0.5 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0364 per EA (NDC 00093342501), effective Nov 11, 2026.

How has the price of LORAZEPAM 0.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for LORAZEPAM 0.5 MG TABLET has declined 9.0%. It has been tracked across 247 weekly CMS publications since Feb 23, 2022.

What are the highest and lowest recorded NADAC prices for LORAZEPAM 0.5 MG TABLET?

Since Feb 23, 2022, the NADAC for LORAZEPAM 0.5 MG TABLET has ranged from a low of $0.0315 (Nov 20, 2024) to a high of $0.0464 (Mar 13, 2024), with a median of $0.0398 per EA.

Are there cheaper alternatives to LORAZEPAM 0.5 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LORAZEPAM 0.5 MG TABLET, is $0.0203 per EA — about 44% below LORAZEPAM 0.5 MG TABLET.

Who manufactures LORAZEPAM 0.5 MG TABLET?

LORAZEPAM 0.5 MG TABLET (NDC 00093342501) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.